ClinicalTrials.Veeva

Menu

Behavioral and Cognitive Predictors of Persistent Pain and Opioid Misuse in Chronic Pain

Mount Sinai Health System logo

Mount Sinai Health System

Status

Enrolling

Conditions

Chronic Back Pain

Treatments

Other: No Intervention

Study type

Observational

Funder types

Other

Identifiers

NCT06288282
STUDY-23-01287

Details and patient eligibility

About

Chronic lower back pain (CLBP) affects approximately 20% of the global population. The study objective is to determine if impulsivity, inhibitory control, drug choice, and/or cognitive distortions predict opioid misuse and disability in patients with chronic pain. This is a prospective consented cross-sectional study characterizing behavioral and cognitive phenotypes using both patient-reported survey measures and cognitive testing. Outcome measures include correlations between impulsivity measures, opioid drug choice responses and cognitive distortion scores, and risk for opioid misuse (Primary outcomes: COMM scores, SOAPPR scores). Secondary outcomes is BPI measurement. A Certificate of Confidentiality will provide additional protections for participants.

Enrollment

130 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • With diagnoses related to chronic lower back pain
  • Age above 18yrs
  • Non pregnant

Exclusion criteria

  • Cancer pain

Trial design

130 participants in 1 patient group

Patients with chronic back pain with lumbar, cervical or thoracic spine diagnoses.
Treatment:
Other: No Intervention

Trial contacts and locations

1

Loading...

Central trial contact

Chinwe Nwaneshiudu, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems